Canada Gets 2nd Generic Semaglutide, Easing Diabetes Costs

0:00Health Canada just approved the second-genered version of semaglutide, the active ingredient in popular drugs like ozempic, wego v, and mongaro. This one's made by the Canadian company, Apotex, bringing another affordable option to the table. Earlier this week, they ok'd the first generic on Tuesday night. That's produced by Dr. Reddy's Laboratories in India and targets once weekly injections for adults with type 2 diabetes. These approvals mean patients managing blood sugar now have homegrown and imported alternatives to pricey brand names. It could ease the burden for folks dealing with diabetes costs. Supply chains are ramping up, with both versions focusing on that same reliable treatment schedule. No word yet on exact launch dates or pricing. As more generics roll in, this shift promises better access across Canada, so stay tuned for how it plays out in pharmacies nationwide. I'm Corey with the story, and you've been listening to Canada News today, AI-powered local news.